SUZZI, FABRIZIA
SUZZI, FABRIZIA
DIMEC - DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Early CTLA4 increase in CD45+ blood cells: an emerging biomarker of atezolizumab–bevacizumab resistance and worse survival in advanced hepatocarcinoma
2025 Gramantieri, L.; Montagner, A.; Arleo, A.; Suzzi, F.; Bassi, C.; Tovoli, F.; Bruccoleri, M.; Alimenti, E.; Fornari, F.; Iavarone, M.; Negrini, M.; Piscaglia, F.; Giovannini, C.
Circulating CD8 lymphocytes predict response to atezolizumab–bevacizumab in hepatocellular carcinoma
2024 Gramantieri L.; Suzzi F.; Bassi C.; D'Abundo L.; Tovoli F.; Bruccoleri M.; Marseglia M.; Alimenti E.; Fornari F.; Negrini M.; Iavarone M.; Piscaglia F.; Giovannini C.
Multifaceted Aspects of Dysfunctional Myelopoiesis in Cancer and Therapeutic Perspectives with Focus on HCC
2024 Arleo, Andrea; Montagner, Annapaola; Giovannini, Catia; Suzzi, Fabrizia; Piscaglia, Fabio; Gramantieri, Laura
Notch Signaling and PD-1/PD-L1 Interaction in Hepatocellular Carcinoma: Potentialities of Combined Therapies
2024 Montagner, Annapaola; Arleo, Andrea; Suzzi, Fabrizia; D'Assoro, Antonino B.; Piscaglia, Fabio; Gramantieri, Laura; Giovannini, Catia
Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab–Bevacizumab in Hepatocellular Carcinoma
2023 Giovannini, Catia; Suzzi, Fabrizia; Tovoli, Francesco; Bruccoleri, Mariangela; Marseglia, Mariarosaria; Alimenti, Eleonora; Fornari, Francesca; Iavarone, Massimo; Piscaglia, Fabio; Gramantieri, Laura
Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area
2022 Gramantieri L.; Gnudi F.; Vasuri F.; Mandrioli D.; Fornari F.; Tovoli F.; Suzzi F.; Vornoli A.; D'errico A.; Piscaglia F.; Giovannini C.
Hepatic cancer stem cells: Molecular mechanisms, therapeutic implications, and circulating biomarkers
2021 Gramantieri L.; Giovannini C.; Suzzi F.; Leoni I.; Fornari F.